Recall: D-0036-2027
Class II - Potentially Harmful
Class IIClassification
2026-09-24Initiated
OngoingStatus
Apothecary Pharma LLCFirm
Product
Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18.
Reason
Lack of Assurance of Sterility
Distribution
Nationwide within the United States
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.